PRAX
$291.23+3.64%
as of close, Sep 30, 2026
☾ AH $291.23 +3.64%
Praxis Precision Medicines Inc.Stock · Health CareRussell 2000 0.3%Nasdaq Composite 0.02%US Stock Market 0.01%Russell 3000 0.01%
PRAX financial statements
The full income statement, balance sheet, and cash-flow statement for Praxis Precision Medicines Inc. (PRAX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 17.8M2024-09 18.6M2024-12 20.2M2025-03 20.4M2025-06 21.0M2025-09 25.0M2025-12 25.2M2026-03 27.9M2026-06 27.9M+57.2% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 0.00-100.0% | 8.55M+249.5% | 2.45M | 0.00 | — | |
| 326M+56.3% | 209M+62.0% | 129M-40.1% | 215M+28.5% | 167M+170.0% | ||
| Research & development | 267M+75.3% | 152M+75.7% | 86.8M-44.0% | 155M+28.9% | 120M+167.4% | |
| Selling, general & administrative | 59.1M+4.9% | 56.3M+33.9% | 42.1M-29.8% | 59.9M+27.3% | 47.1M+177.0% | |
| General & administrative | 59.1M+4.9% | 56.3M+33.9% | 42.1M-29.8% | 59.9M+27.3% | 47.1M+177.0% | |
| Operating income | -326M-63.0% | -200M-58.4% | -126M+41.2% | -215M-28.5% | -167M-170.0% | |
| Other non-operating income | 22.9M+32.2% | 17.3M+460.3% | 3.10M+223.5% | 957K+253.1% | 271K+93.6% | |
| Pre-tax income | -303M-65.7% | -183M-48.6% | -123M | — | -167M-170.2% | |
| Income tax | 471K | — | — | — | 0.00+100.0% | |
| -303M-65.9% | -183M-48.3% | -123M+42.4% | -214M-28.1% | -167M-170.2% | ||
| Net income to common | — | — | — | — | -167M-137.6% | |
| -$13.48-32.0% | -$10.21+45.4% | -$18.69+73.2% | -$69.65-1667.8% | -$3.94+49.9% | ||
| EPS (basic) | -$13.48-32.0% | -$10.21+45.4% | -$18.69+73.2% | -$69.65-1667.8% | -$3.94+49.9% | |
| Weighted-avg shares (basic) | 22.5M+25.7% | 17.9M+171.5% | 6.59M+114.6% | 3.07M-92.8% | 42.5M+374.3% | |
| Weighted-avg shares (diluted) | 22.5M+25.7% | 17.9M+171.5% | 6.59M+114.6% | 3.07M-92.8% | 42.5M+374.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 611M+51.1% | 404M+376.4% | 84.9M-23.4% | 111M-61.4% | 287M-4.9% | ||
| Cash & equivalents | 357M+65.9% | 215M+164.9% | 81.3M+31.9% | 61.6M-55.6% | 139M-53.2% | |
| Short-term investments | 242M+36.6% | 177M | — | — | — | |
| Cash & short-term investments | 926M+97.3% | 470M | 0.00 | — | 276M | |
| Prepaid expenses | 11.6M-1.9% | 11.8M+229.7% | 3.58M-65.4% | 10.4M-10.0% | 11.5M+101.1% | |
| 938M+94.1% | 483M+449.3% | 87.9M-23.6% | 115M-60.7% | 293M-3.4% | ||
| Property, plant & equipment | 147K-36.1% | 230K-60.9% | 588K-39.4% | 971K-20.0% | 1.21M+1379.3% | |
| Operating lease right-of-use | 92.0K-91.9% | 1.13M-45.2% | 2.06M-28.9% | 2.90M-20.6% | 3.65M+384.5% | |
| Intangible assets | 0.00 | — | — | — | — | |
| Long-term investments | 327M+324.6% | 77.0M | — | — | — | |
| Other non-current assets | 0.00-100.0% | 416K+0.0% | 416K+0.0% | 416K-11.9% | 472K+3046.7% | |
| 59.8M+59.2% | 37.5M+138.4% | 15.7M-54.1% | 34.3M-10.6% | 38.4M+144.5% | ||
| Accounts payable | 24.6M+96.6% | 12.5M+115.4% | 5.82M-60.4% | 14.7M+36.1% | 10.8M+163.7% | |
| Accrued liabilities | 35.0M+47.4% | 23.8M+220.4% | 7.42M-53.2% | 15.8M-41.0% | 26.8M+147.0% | |
| Deferred revenue | — | 0.00-100.0% | 1.39M-50.6% | 2.82M | 0.00 | |
| Current lease liability | 110K-91.3% | 1.26M+11.8% | 1.13M+12.0% | 1.00M+24.1% | 810K+6.2% | |
| 59.8M+58.7% | 37.7M+106.0% | 18.3M-53.2% | 39.0M-6.9% | 41.9M+166.8% | ||
| Deferred revenue (non-current) | — | 0.00-100.0% | 1.16M-46.8% | 2.18M | 0.00 | |
| Non-current lease liability | 0.00-100.0% | 110K-92.0% | 1.37M-45.1% | 2.50M-28.7% | 3.50M | |
| Operating lease liability (total) | 110K-92.0% | 1.37M-45.1% | 2.50M-28.7% | 3.50M-18.8% | 4.31M+465.0% | |
| 878M+97.1% | 445M+539.4% | 69.7M-8.5% | 76.1M-69.7% | 251M-12.7% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 15.0K+7.1% | 14.0K+7.7% | 13.0K+160.0% | 5.00K+0.0% | 5.00K+25.0% | |
| Additional paid-in capital | 2.02B+57.4% | 1.28B+77.1% | 724M+19.2% | 607M+6.9% | 568M+29.9% | |
| Retained earnings | -1.14B-36.2% | -837M-28.0% | -654M-23.2% | -531M-67.6% | -317M-111.7% | |
| Accumulated other comprehensive income | 563K-13.9% | 654K | 0.00+100.0% | -173K+1.7% | -176K | |
| Total liabilities & equity | 938M+94.1% | 483M+449.3% | 87.9M-23.6% | 115M-60.7% | 293M-3.4% | |
| Common shares issued | 25.2M+29.7% | 19.4M+120.9% | 8.79M+167.1% | 3.29M-92.7% | 45.3M+18.4% | |
| Common shares outstanding | 25.2M+29.7% | 19.4M+120.9% | 8.79M+167.1% | 3.29M-92.7% | 45.3M+18.4% | |
| Shares outstanding (cover) | 27.9M+38.1% | 20.2M+52.3% | 13.2M-74.7% | 52.4M+15.2% | 45.5M+17.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -249M-89.0% | -132M-18.6% | -111M+39.9% | -185M-48.6% | -125M-136.7% | ||
| Depreciation & amortization | 140K-60.9% | 358K-17.1% | 432K+3.1% | 419K+130.2% | 182K+264.0% | |
| Share-based compensation | 33.9M-17.9% | 41.4M+66.4% | 24.9M-13.1% | 28.6M+26.0% | 22.7M+335.5% | |
| Change in payables | 12.1M+80.2% | 6.71M+175.8% | -8.86M-327.5% | 3.89M-46.4% | 7.27M+657.0% | |
| Other operating activities | 0.00-100.0% | 2.00K | 0.00-100.0% | 56.0K+236.6% | -41.0K-920.0% | |
| -311M-25.2% | -248M-738.0% | 39.0M-59.8% | 96.9M+169.0% | -141M | ||
| Capital expenditure | 56.0K | 0.00-100.0% | 50.0K-88.7% | 444K-57.7% | 1.05M | |
| Free cash flow | -249M-89.1% | -132M-18.5% | -111M+40.1% | -185M-47.7% | -126M-138.7% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 702M+36.5% | 514M+459.8% | 91.9M+777.9% | 10.5M-90.3% | 108M-64.7% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 98.4M | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 142M+5.9% | 134M+581.1% | 19.7M+125.3% | -77.7M+50.7% | -157M-162.5% | |
| Income taxes paid | 224K | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 7.43B+378.6% | 1.55B-45.8% | 2.86B+70.3% | 1.68B-87.5% | 13.4B-57.8% | |
| P/S | — | 181.4×-87.8% | 1482.5× | — | — | |
| P/B | 8.5×+142.8% | 3.5×-89.4% | 33.0×+106.4% | 16.0×-70.2% | 53.6×-51.6% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: PRAX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PRAX filings on SEC EDGAR → Not investment advice.